Darren Heiner
Optometrist · Caldwell, IDNPI 1780935007
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,455 of the $3,616 with a category attached, or 67.9%. Johnson & Johnson Vision Care, Inc. accounts for 90.0% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2024 at $2,963 and has fallen 91.9% since, to $240 in 2025. Among optometrist clinicians in ID with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 34 payments — averaging $106.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Vision Care, Inc.$3K
- Alcon$169
- Biotissue Holdings Inc.$86
- Astellas Pharma US Inc$47
- Bausch & Lomb Americas Inc.$35
- Johnson & Johnson Surgical Vision, Inc.$16
- plus $8 from 1 others
What the payments were for
- Travel & lodging$2,45568%
- Food & beverage$1,15432%
- Education$70%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Vision Care, Inc. | 22 | $3,255 |
| Alcon | 5 | $169 |
| Biotissue Holdings Inc. | 2 | $86 |
| Astellas Pharma US Inc | 2 | $47 |
| Bausch & Lomb Americas Inc. | 1 | $35 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $16 |
| Maculogix, Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Acuvue$2,847
How this compares
$3,616 in reported general payments places this provider in the 90th percentile of 304 optometrist providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Travoprost | 13 | $1,579 |
| Prednisolone Acetate | 46 | $925 |
| Latanoprost | 44 | $524 |
| ErythromycinErythromycin Base | 16 | $195 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 19 | $124 |
| Timolol Maleate | 19 | $53 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Caldwell
- William BlackCaldwell$67K
- Douglas AdamsCaldwell$6K
- James BewleyCaldwell$4K
- Nicholas GonzalesCaldwell$2K
- Drew DaytonIdaho Falls$198K
- Philip RaineyBoise$175K
- Lavar KofoedBoise$91K
- Jason BeseckerMeridian$29K
- Mark McKellNampa$9K
- Marshall MerrellRexburg$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.